Deepa Hattangadiabout 2 years ago

What is the NVX-CoV2373 coronavirus disease 2019 (COVID-19) vaccine?

Top rated comment
about 2 years ago

NVX-CoV2373 (Novavax) NVX-CoV2373 (Novavax) is produced by employing nanoparticle technology. In this technology, complete genetic sequence of SARS-CoV-2 is used to generate full-length perfusion spike (S) protein which is combined with Matrix-M. Clinical trials are being conducted to conclude the efficacy and side-effects of this vaccine. Recent trials show efficient binding with human receptors. NVX-CoV2373 (Novavax) is administered as 2-dose series with difference of 21 days in between.

Other commentsSign in to post comments. You don't have an account? Sign up now!

Recent MCQs

Show more MCQs

Recent flashcard sets

Show more flashcards